My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Longboard Pharmaceuticals, Inc. - Common Stock (NQ:LBPH)

59.98 UNCHANGED

Last Price Updated: 1:00 PM EST, Nov 29, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Longboard Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >

Neurology-Focused Longboard Pharmaceuticals' Stock Soars Over 200% Today - Here's Why ↗

January 02, 2024

Longboard Pharmaceuticals Inc (NASDAQ: LBPH) released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental

Via Benzinga

Dow Down 100 Points; US Manufacturing PMI Falls In December ↗

January 02, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.28% to 37,584.41 while the NASDAQ...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 02, 2024

Via Benzinga

The Latest Analyst Ratings for Longboard Pharmaceuticals ↗

October 24, 2023

Via Benzinga

The Latest Analyst Ratings for Longboard Pharmaceuticals ↗

June 27, 2023

Via Benzinga

The Latest Analyst Ratings for Longboard Pharmaceuticals ↗

May 10, 2023

Via Benzinga

Recap: Longboard Pharmaceuticals Q1 Earnings ↗

May 09, 2023

Via Benzinga

Citigroup Maintains Buy Rating for Longboard Pharmaceuticals: Here's What You Need To Know ↗

March 09, 2023

Via Benzinga

Earnings Preview: Longboard Pharmaceuticals ↗

March 01, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2023 ↗

April 27, 2023

Via Benzinga

Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗

April 27, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Longboard Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2022

Longboard Pharmaceuticals (NASDAQ:LBPH) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy ↗

April 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗

August 18, 2022

Gainers

Via Benzinga

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗

August 17, 2022

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...

Via Benzinga

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight ↗

April 03, 2022

Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...

Via Benzinga

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

Longboard Pharmaceuticals: Q1 Earnings Insights ↗

March 04, 2022

Longboard Pharmaceuticals (NASDAQ:LBPH) reported its Q1 earnings results on Thursday, March 3, 2022 at 04:05 PM. Here's what investors need to know about the...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 23, 2022

On Thursday, 216 stocks hit new 52-week lows.

Via Benzinga

40 Stocks Moving In Tuesday's Mid-Day Session ↗

July 13, 2021

Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 81.7% to $12.12 after the company announced its Global Telesat Communications unit has entered into an agreement with Alibaba....

Via Benzinga

Mid-Morning Market Update: Markets Mixed; JPMorgan Beats Q2 Views ↗

July 13, 2021

Following the market opening Tuesday, the Dow traded down 0.25% to 34,908.83 while the NASDAQ rose 0.15% to 14,754.89. The S&P also fell, dropping 0.07% to 4,381.77. The U.S....

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex ↗

June 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc...

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 15, 2021

Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as...

Via Benzinga

64 Biggest Movers From Friday ↗

June 14, 2021

Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...

Via Benzinga

Topics Initial Public Offering

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.